Holen Sie sich die Stockscreener-App
77.45
1.21%
0.87
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CVS?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$76.58
Offen:
$78.99
24-Stunden-Volumen:
3.05M
Relative Volume:
0.35
Marktkapitalisierung:
$99.25B
Einnahmen:
$402.11B
Nettoeinkommen (Verlust:
$1.73B
KGV:
55.98
EPS:
1.3835
Netto-Cashflow:
$7.81B
1W Leistung:
-0.15%
1M Leistung:
+8.43%
6M Leistung:
-6.67%
1J Leistung:
+18.93%
1-Tages-Spanne:
$76.60
$79.05
1-Wochen-Bereich:
$74.78
$79.05
52-Wochen-Spanne:
$58.35
$85.15
Cvs Health Corp Stock (CVS) Company Profile
Firmenname
Cvs Health Corp
Sektor
Branche
Telefon
(401) 765-1500
Adresse
ONE CVS DR., WOONSOCKET
Compare CVS vs UNH, CI, ELV, HUM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
77.44 | 98.15B | 402.11B | 1.73B | 7.81B | 1.3835 |
UNH
Unitedhealth Group Inc
|
351.21 | 293.61B | 447.57B | 12.81B | 16.08B | 13.19 |
CI
Cigna Group
|
279.14 | 73.80B | 274.88B | 6.29B | 8.39B | 22.19 |
ELV
Elevance Health Inc
|
327.47 | 70.15B | 199.13B | 5.66B | 3.17B | 25.11 |
HUM
Humana Inc
|
220.36 | 25.25B | 129.66B | 1.20B | 375.00M | 9.8083 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-12 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2025-10-14 | Eingeleitet | Goldman | Buy |
| 2025-08-18 | Hochstufung | UBS | Neutral → Buy |
| 2025-08-14 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2025-02-13 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-02-12 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-30 | Hochstufung | Edward Jones | Hold → Buy |
| 2024-12-03 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-11-18 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-10-10 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2024-10-04 | Hochstufung | TD Cowen | Hold → Buy |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Neutral |
| 2024-05-07 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-05-02 | Herabstufung | UBS | Buy → Neutral |
| 2024-05-01 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2024-05-01 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2023-12-22 | Eingeleitet | HSBC Securities | Buy |
| 2023-09-19 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-09-12 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-08-18 | Herabstufung | Edward Jones | Buy → Hold |
| 2023-05-26 | Eingeleitet | Piper Sandler | Overweight |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-01-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2022-03-29 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-02-11 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2021-12-14 | Eingeleitet | Goldman | Buy |
| 2021-12-01 | Eingeleitet | Seaport Research Partners | Buy |
| 2021-05-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2021-03-17 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-01-08 | Hochstufung | Jefferies | Hold → Buy |
| 2020-09-17 | Eingeleitet | Piper Sandler | Overweight |
| 2020-07-01 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2020-05-14 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2019-09-27 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Buy |
| 2019-06-05 | Hochstufung | Standpoint Research | Hold → Buy |
| 2019-04-29 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2019-04-18 | Eingeleitet | Guggenheim | Buy |
| 2019-04-15 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2019-04-10 | Bestätigt | BofA/Merrill | Buy |
| 2019-03-13 | Eingeleitet | Bernstein | Outperform |
| 2019-02-20 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2019-01-17 | Eingeleitet | UBS | Buy |
| 2018-12-18 | Eingeleitet | Barclays | Overweight |
| 2018-11-29 | Fortgesetzt | Goldman | Neutral |
| 2018-11-28 | Eingeleitet | Evercore ISI | Outperform |
| 2018-10-26 | Fortgesetzt | Wolfe Research | Peer Perform |
| 2018-07-09 | Hochstufung | Citigroup | Neutral → Buy |
| 2018-02-27 | Fortgesetzt | BofA/Merrill | Buy |
| 2018-02-13 | Bestätigt | Citigroup | Neutral |
Alle ansehen
Cvs Health Corp Aktie (CVS) Neueste Nachrichten
CVS Pharmacy makes cold & cough relief easier with delivery straight to your door - CVS Health
CVS Health Corp Stock (CVS) Opened Up by 3.02% on Apr 21: Key Drivers Unveiled - TradingKey
CVS Stock Rises Following UnitedHealth's Quarterly Announcement - GuruFocus
Here's What to Expect From CVS Health's Next Earnings Report - Barchart.com
Lobbying Update: $3,320,000 of CVS HEALTH (AND SUBSIDIARIES) lobbying was just disclosed - Quiver Quantitative
CVS Division Enters Chapter 11 Liquidation Sale After $1B Ruling - thestreet.com
CVS Pharmacy: Amid Retail Pressures, Pharmacy Benefits Push Gains Momentum - AD HOC NEWS
CVS Health Corp (CVS) Stock Price, Trades & News - GuruFocus
CVS Stock Quote Price and Forecast - CNN
Benson Investment Management Company Inc. Makes New Investment in CVS Health Corporation $CVS - MarketBeat
AE Wealth Management LLC Has $19.38 Million Holdings in CVS Health Corporation $CVS - MarketBeat
Baird Turns More Bullish on CVS, Nudges Price Target Higher - Yahoo Finance
CVS Pharmacy: Amid Economic Turmoil, Retail Health Resilience Emerges - AD HOC NEWS
Should you buy CVS Health stock before May 6? - MSN
Dividend Roundup: Johnson & Johnson, Costco, Caterpillar, CVS Health, and more - Seeking Alpha
Q4 Earnings Roundup: CVS Health (NYSE:CVS) And The Rest Of The Health Insurance Providers Segment - Yahoo Finance
CVS Health Corporation $CVS Shares Acquired by KBC Group NV - MarketBeat
CVS Stock Price, Quote & Chart | CVS HEALTH CORP (NYSE:CVS) - ChartMill
Man with AR-style pistol arrested at Aetna Hartford headquarters, police say - CT Insider
CVS Health Corp. stock outperforms competitors on strong trading day - MarketWatch
CVS distribution center workers plan to go on strike - Reuters
Should You Forget CVS Health and Invest in a Purer Healthcare Play? - Yahoo Finance
CVS-owned pharmacy bankrupt after $1b whistleblower case & now faces liquidation - the-sun.com
Jim Cramer Shares Big Advantage For CVS Health Corporation (CVS) - Insider Monkey
CVS Caremark Advances Prior Authorization to Get Specialty Medications to Patients Faster - ACCESS Newswire
Lbp Am Sa Sells 19,605 Shares of CVS Health Corporation $CVS - MarketBeat
You know about CVS and Hasbro, but what about these iconic RI brands? - The Providence Journal
Martin Shkreli Says Elizabeth Warren Shoots From The Hip And Is Wrong About Tesla, Disney And Palantir Pa - Benzinga
CVS Health Corp (CVS) Shares Fall 3.4% -- What GF Score of 83 Te - GuruFocus
CVS Health Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
CVS Maintains Outperform Rating -- Price Target Raised to $94 - GuruFocus
CVS Omnicare heads for bankruptcy saleProvidence Business First - The Business Journals
CVS slides 3.1% as investors refocus on PBM legal/regulatory overhang after recent sector optimism - Quiver Quantitative
This Week’s Health IT Jobs – April 15, 2026 - Healthcare IT Today
Here is What to Know Beyond Why CVS Health Corporation (CVS) is a Trending Stock - Yahoo! Finance Canada
Baird Adjusts CVS Health Price Target to $94 From $92, Maintains Outperform Rating - marketscreener.com
CVS Health (NYSE:CVS) Price Target Raised to $94.00 - MarketBeat
CVS Health Corporation $CVS Position Boosted by Assetmark Inc. - MarketBeat
2 Recession Resistant Dividend Stocks to Buy Now While They're Still Cheap - AOL.com
CVS Health Corp. stock (US1266501006): Is its pharmacy-services dominance now the real growth engine - AD HOC NEWS
How Investors Are Reacting To CVS Health (CVS) Insulin Case Settlement Talks And Shareholder Rights Clash - Yahoo Finance
CVS Health Faces FTC Insulin Deal And Proxy Access Governance Test - Yahoo Finance
CVS Health Corp. stock (US1266501006): Why does its pharmacy-services pivot matter more now for U.S. - AD HOC NEWS
Patton Fund Management Inc. Boosts Holdings in CVS Health Corporation $CVS - MarketBeat
Third View Private Wealth LLC Takes Position in CVS Health Corporation $CVS - MarketBeat
CVS Health Corp. stock (US1266501006): Is healthcare integration still delivering value for investor - AD HOC NEWS
CVS Health Corporation (NYSE:CVS) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
CVS Health Just Got a $13 Billion Reprieve. Here's Why the Stock Could Keep Climbing. - AOL.com
CVS Health Just Got a $13 Billion Reprieve. Here's Why the Stock Could Keep Climbing. - The Motley Fool
CVS Health (CVS) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance
CVS Health Corp. stock underperforms Monday when compared to competitors - MarketWatch
Finanzdaten der Cvs Health Corp-Aktie (CVS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.16%
2.52%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):